Related Experiment Video
Updated: Jun 9, 2026

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
Peripheral immune markers in dementia: A systematic review and meta-analysis of risk, severity, and pathological
Ahmad A Toubasi1, Thuraya N Al-Sayegh2
1Department of Neurology Vanderbilt University Medical Center (VUMC) Nashville Tennessee USA.
Introduction:
Systemic inflammation and innate immune activation have been implicated in dementia; however, prior studies were limited by small sample sizes. We conducted this study to evaluate the association between peripheral immune markers and the future risk of mild cognitive impairment (MCI) and dementia, their ability to differentiate between dementia causes, and their correlation with disease severity and pathological biomarkers.
Methods:
On September 8, 2025, we searched PubMed, Embase, Scopus, and the Cochrane Central Register of Controlled Trials (CENTRAL). Eligible articles included cohort and case-control studies assessing the association between neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), or systemic inflammatory index (SII) and the risk of developing MCI or dementia, as well as their association with disease severity and pathological biomarkers. Outcomes were the risk of MCI and dementia (Alzheimer's disease, vascular dementia, and Parkinson's disease dementia), dementia severity assessed by the Mini-Mental State Examination, and cerebrospinal fluid or pathological markers including amyloid beta (Aβ)42, Aβ40, and tau. Hazard ratios (HRs) with 95% confidence intervals (CIs) were pooled as effect estimates.
Results:
Our analysis included 947,020 participants from 23 studies. NLR and SII, but not PLR, were associated with increased risk of dementia (NLR: HR = 1.24, 95% CI: 1.15-1.34; SII: HR = 1.08, 95% CI: 1.03-1.13) and MCI (NLR: HR = 2.78, 95% CI: 1.57-4.90; SII: HR = 1.28, 95% CI: 1.04-1.56). No differential associations were observed across dementia causes. NLR and SII were correlated with worse dementia (NLR: r = -0.22, p = 0.033; SII: r = -0.17, p = 0.041) and MCI severity (NLR: r = -0.30, p = 0.010; SII: r = -0.23, p = 0.025). NLR, but not SII, was associated with Aβ42, Aβ40, and tau.
Discussion:
NLR and SII may provide valuable insights when advanced biomarker testing is limited by technological or financial barriers.
More Related Videos
10:52Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques
Published on: June 1, 2016
12:48In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma
Published on: May 11, 2015
Related Concept Videos
Dementia l: Introduction
Alzheimer Disease ll: Pathophysiology
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Dementia
The progression of dementia is generally gradual.
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation